Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circular RNA vaccines against SARS-CoV-2 and emerging variants
Liang Qu, Zongyi Yi, Yong Shen, et al.
Cell (2022) Vol. 185, Iss. 10, pp. 1728-1744.e16
Open Access | Times Cited: 374

Showing 1-25 of 374 citing articles:

Circular RNAs: Characterization, cellular roles, and applications
Chu‐Xiao Liu, Ling‐Ling Chen
Cell (2022) Vol. 185, Iss. 12, pp. 2016-2034
Open Access | Times Cited: 588
Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 392
RNA-based therapeutics: an overview and prospectus
Yiran Zhu, Liyuan Zhu, Xian Wang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 344
The landscape of mRNA nanomedicine
Xiangang Huang, Na Kong, Xingcai Zhang, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2273-2287
Open Access | Times Cited: 301
mRNA-based cancer therapeutics
Chuang LIU, Qiangqiang Shi, Xiangang Huang, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 8, pp. 526-543
Closed Access | Times Cited: 201
COVID-19 mRNA vaccines: Platforms and current developments
Gábor Szabó, Azita J. Mahiny, Irena Vlatkovic
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1850-1868
Open Access | Times Cited: 194
Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines
Xiang Liu, Yu Zhang, Shurong Zhou, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 84-94
Open Access | Times Cited: 162
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy
Yan Zong, Yi Lin, Tuo Wei, et al.
Advanced Materials (2023) Vol. 35, Iss. 51
Closed Access | Times Cited: 161
Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
Yunlong Cao, Ayijiang Yisimayi, Yali Bai, et al.
Cell Research (2021) Vol. 31, Iss. 7, pp. 732-741
Open Access | Times Cited: 153
The humoral response and antibodies against SARS-CoV-2 infection
Hai Qi, Bo Liu, Xinquan Wang, et al.
Nature Immunology (2022) Vol. 23, Iss. 7, pp. 1008-1020
Open Access | Times Cited: 144
Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies
Hongjian Li, Kun Peng, Kai Yang, et al.
Theranostics (2022) Vol. 12, Iss. 14, pp. 6422-6436
Open Access | Times Cited: 109
Advances in Circular RNA and Its Applications
Xian Zhao, Youxiu Zhong, Xudong Wang, et al.
International Journal of Medical Sciences (2022) Vol. 19, Iss. 6, pp. 975-985
Open Access | Times Cited: 107
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
Danyi Ao, Tianxia Lan, Xuemei He, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 105
Nanotechnology-based strategies against SARS-CoV-2 variants
Xiangang Huang, Edo Kon, Xuexiang Han, et al.
Nature Nanotechnology (2022) Vol. 17, Iss. 10, pp. 1027-1037
Open Access | Times Cited: 101
Extracellular vesicles: The next generation in gene therapy delivery
Riccardo Cecchin, Zach Troyer, Ken Witwer, et al.
Molecular Therapy (2023) Vol. 31, Iss. 5, pp. 1225-1230
Open Access | Times Cited: 88
Exosomal circRNA: emerging insights into cancer progression and clinical application potential
Fan Zhang, Jiajia Jiang, Hui Qian, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 85
RNA therapeutics: updates and future potential
Caroline Zhang, Biliang Zhang
Science China Life Sciences (2022) Vol. 66, Iss. 1, pp. 12-30
Open Access | Times Cited: 77
Circular RNA vaccine in disease prevention and treatment
Dun Niu, Yaran Wu, Jiqin Lian
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 75
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides
Di Huang, Xiao‐Feng Zhu, Shuying Ye, et al.
Nature (2023) Vol. 625, Iss. 7995, pp. 593-602
Closed Access | Times Cited: 75
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 74
Circular RNA vaccine induces potent T cell responses
Laura Amaya, Lilit Grigoryan, Zhijian Li, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 20
Open Access | Times Cited: 70
mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 65
Clinical delivery of circular RNA: Lessons learned from RNA drug development
Tiana L. Young, Kevin Chang Wang, Andrew Varley, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114826-114826
Closed Access | Times Cited: 62
Research Advances on the Stability of mRNA Vaccines
Feiran Cheng, Yi‐Ping Wang, Yu Bai, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 668-668
Open Access | Times Cited: 56
Aptamer-Based Targeted Delivery of Functional Nucleic Acids
Sitao Xie, Weidi Sun, Ting Fu, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 14, pp. 7677-7691
Closed Access | Times Cited: 56
Page 1 - Next Page

Scroll to top